Skip to main content
. 2014 Feb 3;8:347–354. doi: 10.2147/OPTH.S57640

Figure 1.

Figure 1

IOP before and after travoprost with sofZia® administration.

Notes: IOP is presented as the mean ± SD. *P<0.0001 for significant change of IOP compared with baseline by repeated measures analysis of variance and multiple comparison using Tukey’s HSD test. sofZia® (Travatan® 0.004%, Alcon Laboratories, Inc., Fort Worth, TX, USA).

Abbreviations: HSD, honestly significant difference; IOP, intraocular pressure; SD, standard deviation.